Dive into the dynamic world of ALK+ NSCLC treatment with Dr. Millie Das, a prominent figure in oncology, as she unveils the journey and rigorous processes behind the approval of current medications. Hosted by the 2022 Targeted Therapies Forum, this session offers a rich blend of insight and knowledge.
Heartfelt thanks to our esteemed sponsors: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech, whose dedication fuels the advancement in cancer care.
Stay updated with the latest in cancer treatments and join our growing community. Discover more at http://cancerGRACE.org/. For engaging discussions and shared experiences, head over to https://cancergrace.org/forum.